Patent protection and factors unique to prescription drugs weaken the forces keeping prices near costs for other products. A growing public consensus that affordable drugs should be available to all is likely to increase the upward pressure on prices. To restore competition to all parts of the pharmaceutical industry, we propose a new institute at the National Institutes of Health that would co...

João Carapinha (BPharm, MM P&DM) is the owner of PharmaLogica, a consulting company active in South Africa and the USA. Its aim is to respond with effective and innovative insight to the needs of the pharmaceutical sector in developing countries. PharmaLogica has worked for non-profit institutions, government agencies and also consulted on a project basis for pharmaceutical companies. This rese...

This article considers overview of the integration process isolated power systems Yakutia to eastern section Unified Power System Russia. Features development Yakutia’s electric sector are considered. Systemic effects connecting IPS Far East were identified. Changes in tariff setting analysed. Information about improving reliability electricity supply was presented.

Trenzyme GmbH (S.T.), Byk-Gulden –Str. 2, D-78467 Konstanz, Germany; Lead Identification and Optimization Support (L.H., S.H., R.H.), Immunological and Respiratory Diseases Research (H.S.), CNS Diseases Research (H.R.), Target Discovery Research (E.S.); Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, D-88397 Biberach, Germany; Biotherapeutics Discovery (L.F.); Boehringer Ingelh...

BACKGROUND This paper has set out to map the state of pharmaceutical regulation in the developing world through the construction of cross-national indices drawing from World Health Organization data. The last two decades have been characterized by deep changes for the pharmaceutical sector, including the complete transformation of intellectual property systems at the behest of the World Trade O...

pharmaceutical sector in the past decade is well documented1. Many of these analyses have attempted to identify specific causes leading to such questionable performance metrics, as well as suggest possible solutions1-5. In the latter case it has involved consideration of better technology investments; build-out of IT, bioinformatics and knowledge management tools; creation of efficient decision...

To study the participation of the private sector in detection and diagnosis of tuberculosis, all suspected cases referring to 4 private laboratories in Tehran for acid-fast bacillus examination during 2002-03 were documented. Of 9037 cases enrolled in the study, 637 had positive examination results (7.1%). Of these 531 (5.9%) cases were direct smear-positive and 489 (5.4%) were culture-positive...

BACKGROUND We utilized our previous studies analyzing the reforms affecting the health sector developed in the 1990s by financial groups to frame the strategies implemented by the pharmaceutical industry to regain market positions and to understand the challenges that regulatory agencies are confronting. METHODS We followed an analytical approach for analyzing the process generated by the dis...